Schedule 13D ownership disclosure

OncBioMune Pharmaceuticals, Inc

Security class unavailable · CUSIP: 68235A101

Event date: 2017-03-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
30,579,007
Percent of class
25.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-17-002595
Form type
SC 13D
Filer
Odabachian Manuel Cosme
CIK
CIK 1700627
Filed
Mar 20, 2017
Reporting period
Mar 10, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub